Synthetic Biologics Inc (SYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYN | AMGN | VRTX | GILD | BMY |
| Company | Synthetic Biologics Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.0200 | 262.18 | 403.14 | 92.62 | 56.93 |
| High | 1.0200 | 263.58 | 409.60 | 92.83 | 57.38 |
| Low | 0.9700 | 258.31 | 402.72 | 91.40 | 56.52 |
| Last | 1.0200 | 259.32 | 405.81 | 91.89 | 56.82 |
| Change | +0.0100 | -1.32 | +3.11 | -0.48 | +0.26 |
| % Change | +0.99% | -0.51% | +0.77% | -0.52% | +0.46% |
| Volume | 57,700 | 1,548,791 | 920,770 | 2,230,000 | 6,398,145 |
| 20-Day Average Volume | 49,125 | 3,711,014 | 1,866,117 | 6,721,315 | 11,088,277 |
| Previous Close | 1.0100 | 260.64 | 402.70 | 92.37 | 56.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1113 | 267.31 | 437.23 | 92.41 | 57.33 |
| 20-Day Raw Stochastic | 11.63% | 22.96% | 28.14% | 52.00% | 36.86% |
| 20-Day Relative Strength | 34.20% | 31.49% | 35.34% | 51.78% | 50.08% |
| Weighted Alpha | -82.00 | -19.48 | -9.98 | +19.82 | +16.04 |
| Today's Opinion | 100% Sell | 88% Sell | 72% Sell | 88% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 88% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 72% Sell | 8% Sell | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.30% since 10/05/22 | -1.91% since 12/24/24 | -0.63% since 12/24/24 | -2.06% since 12/24/24 | -1.70% since 12/24/24 |
| Low | 0.9700 on 10/12/22 | 258.31 on 01/02/25 | 399.06 on 12/30/24 | 91.40 on 01/02/25 | 55.93 on 12/31/24 |
| High | 1.1900 on 10/06/22 | 264.73 on 12/26/24 | 411.29 on 12/26/24 | 94.55 on 12/26/24 | 58.38 on 12/27/24 |
| 1-Month | |||||
| %Chg | -28.17% since 09/12/22 | -6.71% since 12/02/24 | -12.91% since 12/02/24 | -2.14% since 12/02/24 | -5.27% since 12/02/24 |
| Low | 0.9700 on 10/12/22 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 |
| High | 1.4700 on 09/13/22 | 281.38 on 12/03/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 |
| 3-Month | |||||
| %Chg | -57.07% since 07/12/22 | -18.86% since 10/02/24 | -12.24% since 10/02/24 | +8.58% since 10/02/24 | +5.62% since 10/02/24 |
| Low | 0.9700 on 10/12/22 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 83.98 on 10/04/24 | 51.31 on 10/15/24 |
| High | 2.3990 on 07/13/22 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -60.90% since 04/12/22 | -16.52% since 07/02/24 | -14.39% since 07/02/24 | +34.52% since 07/02/24 | +40.37% since 07/02/24 |
| Low | 0.9700 on 10/12/22 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 |
| High | 2.6900 on 04/13/22 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,161 | 140,102,608 | 103,706,928 | 115,117,592 | 114,713,688 |
| Shares Outstanding, K | 15,844 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -14,270,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -4,968,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.38 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 08/11/22 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/02/22 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.620 on 01/03/25 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 0.00 | 20.77 | 47.91 |